Related Experiment Videos
Serum sickness-like illness associated with rifampicin
F M Parra1, M J Pérez Elias, M Cuevas
1Servicio de Alergia, Hospital Ramón y Cajal, Madrid, Spain.
Annals of Allergy
|August 1, 1994
Summary
A patient with human immunodeficiency virus developed serum sickness-like symptoms while on tuberculostatic drugs. Rifampicin triggered a positive skin test, suggesting a drug-induced immune response.
Area of Science:
- Immunology
- Infectious Diseases
- Dermatology
Background:
- Human immunodeficiency virus (HIV) infection can present with complex clinical manifestations.
- Tuberculostatic drugs are essential for managing opportunistic infections in HIV patients.
- Serum sickness-like reactions (SSLRs) are hypersensitivity responses to medications.
Observation:
- A patient with HIV developed symptoms consistent with SSLRs during treatment with daily tuberculostatic agents.
- Laboratory findings included decreased complement titers and elevated circulating immune complexes.
- Intradermal testing with rifampicin elicited a positive skin reaction within six hours.
Findings:
- The clinical presentation, laboratory markers, and positive skin test strongly suggest rifampicin-induced serum sickness-like reaction in an HIV-positive individual.
- Absence of immunoglobulin and complement deposition on skin biopsy indicates a non-vasculitic immune mechanism, possibly immune complex-mediated.
- This case highlights a potential adverse drug reaction to a common tuberculostatic agent in the context of HIV infection.
Implications:
- Clinicians should consider SSLRs in HIV patients presenting with compatible symptoms during tuberculostatic therapy.
- Rifampicin may act as an immunogen, triggering hypersensitivity reactions.
- Further investigation into the immunopathogenesis of SSLRs to tuberculostatic drugs in immunocompromised patients is warranted.